Griptha Putra Persada Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Griptha Putra Persada Tbk. trades at Rp59 (market cap 60B, 661.3K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is far larger — about 2.8× Griptha Putra Persada Tbk.'s market cap, and Griptha Putra Persada Tbk. is more actively traded (661.3K versus 71K). Which is the better fit depends on your goals.
| GRPH | OBAT | |
|---|---|---|
Market Cap | 60B | 167.37B |
Volume | 661.3K | 71K |
Lot | 6.61K | 710 |
Turnover | 39.67M | 17.51M |
Average Price | 59.99 | 246.63 |
Value | 39.67M | 17.51M |
Indicative Equilibrium Price | 59 | 246 |
Indicative Equilibrium Volume | 640 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Griptha Putra Persada Tbk (the Company), was established based on Notarial Deed No. 26 dated April 14, 2010 of Drs. Ika Slamet Riyono, S.H., notary in Kudus. The Company started its commercial operation in July 1, 2015. The Company’s immediate parent company is PT Mulia Jaya Palma and the ultimate controlling shareholder of the Company is Samuel Jeffrey Christiawan Soegeng.
Read more on GRPH →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →